Pimavanserin
ACP-103-046
Phase 3 small_molecule completed
Quick answer
Pimavanserin for Neuropsychiatric Symptoms Related to Neurodegenerative Disease is a Phase 3 program (small_molecule) at ACADIA PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- ACADIA PHARMACEUTICALS INC
- Indication
- Neuropsychiatric Symptoms Related to Neurodegenerative Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed